Transcatheter Aortic Valve Replacement for Bicuspid Aortic Insufficiency After Valve-Sparing Aortic Root Replacement

Koren, Ofir; Patel, Vivek; Kaewkes, Danon; Koseki, Keita; Chakravarty, Tarun; Nakamura, Mamoo; Wen, Cheng P.; Naami, Robert; Makkar, Raj

doi:10.1016/j.jaccas.2021.07.018

Cited by 2 publications

(1 citation statement)

References 7 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After removing duplicates, 639 studies were screened, and 32 full‐text articles were assessed for eligibility. Ultimately, 31 articles 12,17–46 including a total of 86 patients met the inclusion criteria. These studies were published between 2009 and 2023, with sample sizes ranging from 1 to 27 patients, Table 1.…”

Section: Resultsmentioning

confidence: 99%

Transcatheter valve‐in‐valve interventions after aortic root replacement: A systematic review

Baudo,

Cuko,

Ternacle

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

Structural valve deterioration after aortic root replacement (ARR) surgery may be treated by transcatheter valve‐in‐valve (ViV‐TAVI) intervention. However, several technical challenges and outcomes are not well described. The aim of the present review was to analyze the outcomes of ViV‐TAVI in deteriorated ARR. This review included studies reporting any form of transcatheter valvular intervention in patients with a previous ARR. All forms of ARR were considered, as long as the entire root was replaced. Pubmed, ScienceDirect, SciELO, DOAJ, and Cochrane library databases were searched until September 2023. Overall, 86 patients were included from 31 articles that met our inclusion criteria out of 741 potentially eligible studies. In the entire population, the mean time from ARR to reintervention was 11.0 years (range: 0.33–22). The most frequently performed techniques/grafts for ARR was homograft (67.4%) and the main indication for intervention was aortic regurgitation (69.7%). Twenty‐three articles reported no postoperative complications. Six (7.0%) patients required permanent pacemaker implantation (PPI) after the ViV‐TAVI procedure, and 4 (4.7%) patients had a second ViV‐TAVI implant. There were three device migrations (3.5%) and 1 stroke (1.2%). Patients with previous ARR present a high surgical risk. ViV‐TAVI can be considered in selected patients, despite unique technical challenges that need to be carefully addressed according to the characteristics of the previous surgery and on computed tomography analysis.

show abstract

Section: Resultsmentioning

confidence: 99%

Transcatheter valve‐in‐valve interventions after aortic root replacement: A systematic review

Baudo,

Cuko,

Ternacle

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Less invasive treatments for pure aortic insufficiency: Are we there yet?

Forcillo

2022

Journal of Cardiac Surgery

View full text Add to dashboard Cite

The gold standard for the treatment of pure aortic insufficiency (PAI) is surgical valve repair or replacement. With the newest transcatheter heart valve technologies and the accumulating years of experience of heart teams with the current transcatheter aortic valve replacement (TAVR) prostheses, implanters have pushed the envelope with off‐label use of those valves designed and approved for aortic stenosis, in patients with PAI especially those at higher risks or for compassionate use. However, new prostheses are currently under investigation in clinical use and evidence is provided on the safety and efficacy of those latter. Will be discussed in this commentary, the actual clinical evidence and the use of transcatheter heart valves, in‐ and off‐label, for the treatment of PAI.

show abstract

Transcatheter Aortic Valve Replacement for Bicuspid Aortic Insufficiency After Valve-Sparing Aortic Root Replacement

Cited by 2 publications

References 7 publications

Transcatheter valve‐in‐valve interventions after aortic root replacement: A systematic review

Transcatheter valve‐in‐valve interventions after aortic root replacement: A systematic review

Less invasive treatments for pure aortic insufficiency: Are we there yet?

Contact Info

Product

Resources

About